More recently Di Gennaro et al. analyzed the immune cell profile in biopsies from melanoma patients before and after ECT treatment and reported a relevant local immune response, with decreasing CD4 + FOXP3+ T reg cells and recruitment of CD3 + CD8+ T cells in the treated lesions [39]. This evidence concerns the gene CD4 and melanoma.